CYTK
Price
$45.24
Change
-$1.47 (-3.15%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
5.34B
36 days until earnings call
TRDA
Price
$12.49
Change
-$0.88 (-6.58%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
467.38M
56 days until earnings call
Ad is loading...

CYTK vs TRDA

Header iconCYTK vs TRDA Comparison
Open Charts CYTK vs TRDABanner chart's image
Cytokinetics
Price$45.24
Change-$1.47 (-3.15%)
Volume$22.09K
Capitalization5.34B
Entrada Therapeutics
Price$12.49
Change-$0.88 (-6.58%)
Volume$4.42K
Capitalization467.38M
CYTK vs TRDA Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. TRDA commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (CYTK: $45.23 vs. TRDA: $12.49)
Brand notoriety: CYTK and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 113% vs. TRDA: 142%
Market capitalization -- CYTK: $5.34B vs. TRDA: $467.38M
CYTK [@Biotechnology] is valued at $5.34B. TRDA’s [@Biotechnology] market capitalization is $467.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYTK and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 4 bearish.
  • TRDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than TRDA.

Price Growth

CYTK (@Biotechnology) experienced а -6.76% price change this week, while TRDA (@Biotechnology) price change was -27.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

CYTK is expected to report earnings on May 07, 2025.

TRDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.34B) has a higher market cap than TRDA($467M). CYTK YTD gains are higher at: -3.848 vs. TRDA (-27.762). TRDA has higher annual earnings (EBITDA): 61.3M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. TRDA (449M). TRDA has less debt than CYTK: TRDA (61.3M) vs CYTK (790M). TRDA has higher revenues than CYTK: TRDA (215M) vs CYTK (3.22M).
CYTKTRDACYTK / TRDA
Capitalization5.34B467M1,143%
EBITDA-481.94M61.3M-786%
Gain YTD-3.848-27.76214%
P/E RatioN/A8.67-
Revenue3.22M215M1%
Total Cash1.01B449M225%
Total Debt790M61.3M1,289%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKTRDA
RSI
ODDS (%)
Bullish Trend 7 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
83%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
77%
Bearish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
75%
Bearish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEMMX10.420.09
+0.87%
American Century Emerging Markets A
BERCX16.790.13
+0.78%
Carillon Chartwell Mid Cap Value I
SUSYX13.960.10
+0.72%
SEI US Managed Volatility Y (SIMT)
FIFOX23.040.06
+0.26%
Fidelity Advisor Founders A
LGLUX49.570.07
+0.14%
Lord Abbett Growth Leaders R5

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-3.17%
KRON - CYTK
43%
Loosely correlated
+3.13%
DARE - CYTK
42%
Loosely correlated
+0.30%
TRDA - CYTK
41%
Loosely correlated
-6.58%
CKPT - CYTK
41%
Loosely correlated
-0.94%
CGEN - CYTK
39%
Loosely correlated
+0.50%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with PLRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-6.58%
PLRX - TRDA
52%
Loosely correlated
-4.50%
RXRX - TRDA
48%
Loosely correlated
-6.23%
CRNX - TRDA
47%
Loosely correlated
-8.62%
MGTX - TRDA
47%
Loosely correlated
-2.37%
STRO - TRDA
46%
Loosely correlated
-3.91%
More